Oncotelic Therapeutics - 23 Year Stock Price History | OTLC

Historical daily share price chart and data for Oncotelic Therapeutics since 1993 adjusted for splits and dividends. The latest closing stock price for Oncotelic Therapeutics as of December 07, 2016 is 0.35.
  • The all-time high Oncotelic Therapeutics stock closing price was 9607.20 on September 04, 1997.
  • The Oncotelic Therapeutics 52-week high stock price is 0.00, which is -100% above the current share price.
  • The Oncotelic Therapeutics 52-week low stock price is 0.00, which is 100% below the current share price.
  • The average Oncotelic Therapeutics stock price for the last 52 weeks is NaN.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Oncotelic Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2016 0.6345 0.7450 0.8380 0.3499 0.3499 -53.95%
2015 1.3242 1.7000 1.9200 0.7450 0.7599 -52.80%
2014 2.4797 2.7900 4.2900 1.5450 1.6100 -36.11%
2013 3.1798 5.3000 5.3000 2.1100 2.5200 -52.90%
2012 9.0018 11.8800 15.8400 4.0800 5.3500 -54.97%
2011 26.8005 55.2000 67.2000 10.8000 11.8800 -78.48%
2010 155.9429 278.4000 316.8000 48.0000 55.2000 -79.82%
2009 294.1333 156.0000 571.2000 124.8000 273.6000 72.73%
2008 350.4854 580.8000 595.2000 144.0000 158.4000 -73.49%
2007 903.9012 1152.0000 1178.4000 516.0000 597.6000 -48.13%
2006 960.9275 988.8000 1370.4000 684.0000 1152.0000 20.91%
2005 1150.3619 1396.8000 1435.2000 897.6000 952.8000 -27.82%
2004 1694.2571 2047.2000 2642.4000 1027.2000 1320.0000 -32.18%
2003 1614.0952 266.4000 3314.4000 254.4000 1946.4000 672.38%
2002 398.6571 804.0000 825.6000 201.6000 252.0000 -65.80%
2001 1142.0516 1485.6000 1965.6000 468.0000 736.8000 -47.79%
2000 3093.0857 3602.4000 6244.8000 1276.8000 1411.2000 -62.40%
1999 2651.4095 2462.4000 4833.6000 1785.6000 3753.6000 45.35%
1998 2676.4952 4322.4000 4504.8000 1111.2000 2582.4000 -38.55%
1997 6920.4996 5493.6000 9607.2000 3722.4000 4202.4000 -25.55%
1996 4999.5213 2371.2000 7716.0000 2222.4000 5644.8000 121.26%
1995 1589.1619 1140.0000 2642.4000 1080.0000 2551.2000 123.79%
1994 1795.5143 1591.2000 2551.2000 1125.6000 1140.0000 -28.36%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.015B $0.000B
Mateon is a biopharmaceutical company focused on the modulation of transforming growth factor-beta (TGF-beta) for the treatment of cancer and infectious diseases, including COVID-19. The company's lead development compound, OT-101 (trabedersen), is a single stranded antisense oligonucleotide targeting the TGF-beta2 mRNA. Mateon is conducting a Phase 2/3 clinical trial of OT-101 in patients suffering from COVID-19. In addition, the company has initiated a global Phase 4 clinical trial of ArtiShield(TM) in India, Africa, and Latin America for the treatment of COVID-19, with results expected in the 4Q20. ArtiShieldTM received marketing approval from India.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $160.651B 16.08
Regeneron Pharmaceuticals (REGN) United States $105.222B 25.83
Vertex Pharmaceuticals (VRTX) United States $104.030B 26.73
GSK (GSK) United Kingdom $90.048B 10.76
Bristol Myers Squibb (BMY) United States $88.990B 41.81
CSL (CSLLY) Australia $88.658B 0.00
Gilead Sciences (GILD) United States $81.602B 16.26
Moderna (MRNA) United States $46.805B 0.00
Biogen (BIIB) United States $32.238B 14.76
Argenex SE (ARGX) Netherlands $23.403B 0.00
BioNTech SE (BNTX) Germany $22.192B 186.70
Genmab (GMAB) Denmark $19.196B 22.50
Alnylam Pharmaceuticals (ALNY) United States $19.128B 0.00
Illumina (ILMN) United States $18.954B 135.21
BioMarin Pharmaceutical (BMRN) United States $15.589B 60.81
BeiGene (BGNE) Cayman Islands $15.540B 0.00
Sarepta Therapeutics (SRPT) United States $12.764B 1125.33
Incyte (INCY) United States $12.143B 18.78
Bio-Techne Corp (TECH) United States $11.956B 45.27
Exact Sciences (EXAS) United States $11.647B 0.00
QIAGEN (QGEN) Netherlands $9.717B 20.76
Repligen (RGEN) United States $9.389B 122.66
Roivant Sciences (ROIV) United Kingdom $9.348B 0.00
Viking Therapeutics (VKTX) United States $8.624B 0.00
Legend Biotech (LEGN) United States $8.233B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 23.78
Ascendis Pharma (ASND) Denmark $7.802B 0.00
Vaxcyte (PCVX) United States $7.198B 0.00
Intra-Cellular Therapies (ITCI) United States $6.874B 0.00
Cytokinetics (CYTK) United States $6.803B 0.00
Blueprint Medicines (BPMC) United States $6.503B 0.00
Exelixis (EXEL) United States $6.379B 34.22
Apellis Pharmaceuticals (APLS) United States $5.920B 0.00
ImmunityBio (IBRX) United States $5.287B 0.00
Halozyme Therapeutics (HALO) United States $5.191B 16.02
CRISPR Therapeutics AG (CRSP) Switzerland $4.843B 0.00
Zealand Pharma (ZLDPF) Denmark $4.616B 0.00
Krystal Biotech (KRYS) United States $4.475B 0.00
Nuvalent (NUVL) United States $4.437B 0.00
Immunovant (IMVT) United States $4.311B 0.00
Alkermes (ALKS) Ireland $4.078B 15.96
Iovance Biotherapeutics (IOVA) United States $3.884B 0.00
Insmed (INSM) United States $3.855B 0.00
Biohaven (BHVN) United States $3.635B 0.00
Axsome Therapeutics (AXSM) United States $3.607B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.576B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.454B 0.00
SpringWorks Therapeutics (SWTX) United States $3.432B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.259B 0.00
Fortrea Holdings (FTRE) United States $3.248B 0.00
Janux Therapeutics (JANX) United States $3.225B 0.00
IDEAYA Biosciences (IDYA) United States $3.222B 0.00
Immunocore Holdings (IMCR) United Kingdom $3.084B 0.00
Amicus Therapeutics (FOLD) United States $3.062B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.844B 0.00
Certara (CERT) United States $2.826B 60.83
ACADIA Pharmaceuticals (ACAD) United States $2.808B 0.00
Arcellx (ACLX) United States $2.807B 0.00
Merus (MRUS) Netherlands $2.778B 0.00
MorphoSys AG (MOR) Germany $2.708B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.675B 0.00
Twist Bioscience (TWST) United States $2.601B 0.00
Avidity Biosciences (RNA) United States $2.518B 0.00
Vera Therapeutics (VERA) United States $2.480B 0.00
Denali Therapeutics (DNLI) United States $2.443B 0.00
Kymera Therapeutics (KYMR) United States $2.350B 0.00
CG Oncology (CGON) United States $2.339B 0.00
Apogee Therapeutics (APGE) United States $2.331B 0.00
Celldex Therapeutics (CLDX) United States $2.328B 0.00
Guardant Health (GH) United States $2.325B 0.00
Intellia Therapeutics (NTLA) United States $2.288B 0.00
Vericel (VCEL) United States $2.271B 0.00
Geron (GERN) United States $2.212B 0.00
Sana Biotechnology (SANA) United States $2.204B 0.00
Arvinas (ARVN) United States $2.204B 0.00
Keros Therapeutics (KROS) United States $2.173B 0.00
Ginkgo Bioworks Holdings (DNA) United States $2.127B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.105B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.086B 0.00
NeoGenomics (NEO) United States $1.981B 0.00
Galapagos (GLPG) Belgium $1.942B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.912B 0.00
Edgewise Therapeutics (EWTX) United States $1.894B 0.00
Beam Therapeutics (BEAM) United States $1.875B 0.00
Structure Therapeutics (GPCR) United States $1.852B 0.00
Myriad Genetics (MYGN) United States $1.807B 0.00
Bavarian Nordic (BVNRY) Denmark $1.799B 5.91
Inhibrx (INBX) United States $1.793B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.755B 13.38
Zai Lab (ZLAB) China $1.678B 0.00
Kura Oncology (KURA) United States $1.601B 0.00
ADMA Biologics Inc (ADMA) United States $1.577B 0.00
Akero Therapeutics (AKRO) United States $1.529B 0.00
Protagonist Therapeutics (PTGX) United States $1.528B 0.00
Dynavax Technologies (DVAX) United States $1.523B 0.00
Morphic Holding (MORF) United States $1.520B 0.00
Neumora Therapeutics (NMRA) United States $1.491B 0.00
Arcus Biosciences (RCUS) United States $1.451B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.450B 0.00
ANI Pharmaceuticals (ANIP) United States $1.420B 17.45
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.418B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.399B 0.00
Vir Biotechnology (VIR) United States $1.391B 0.00
Spyre Therapeutics (SYRE) United States $1.293B 0.00
Ligand Pharmaceuticals (LGND) United States $1.289B 15.97
Prothena (PRTA) Ireland $1.275B 0.00
Gyre Therapeutics (GYRE) United States $1.266B 0.00
Belite Bio (BLTE) United States $1.262B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.243B 0.00
Cullinan Therapeutics (CGEM) United States $1.223B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.208B 0.00
AbCellera Biologics (ABCL) Canada $1.208B 0.00
Scholar Rock Holding (SRRK) United States $1.201B 0.00
MannKind (MNKD) United States $1.191B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.085B 0.00
MiMedx (MDXG) United States $1.052B 44.56
Viridian Therapeutics (VRDN) United States $0.995B 0.00
Liquidia Technologies (LQDA) United States $0.969B 0.00
Tyra Biosciences (TYRA) United States $0.964B 0.00
Abivax SA (ABVX) France $0.941B 0.00
Immunome (IMNM) United States $0.927B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.918B 0.00
Mesoblast (MESO) Australia $0.915B 0.00
89BIO (ETNB) United States $0.913B 0.00
Praxis Precision Medicines (PRAX) United States $0.909B 0.00
Immatics (IMTX) Germany $0.909B 0.00
Cytek Biosciences (CTKB) United States $0.843B 0.00
Tango Therapeutics (TNGX) United States $0.842B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.832B 0.00
Pliant Therapeutics (PLRX) United States $0.832B 0.00
REGENXBIO (RGNX) United States $0.827B 0.00
ALX Oncology Holdings (ALXO) United States $0.789B 0.00
CARGO Therapeutics (CRGX) United States $0.786B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.756B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.742B 0.00
PureTech Health (PRTC) United States $0.739B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.736B 0.00
Disc Medicine (IRON) United States $0.728B 0.00
Cogent Biosciences (COGT) United States $0.724B 0.00
AnaptysBio (ANAB) United States $0.704B 0.00
WAVE Life Sciences (WVE) Singapore $0.703B 0.00
Dianthus Therapeutics (DNTH) United States $0.702B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.700B 0.00
Nuvation Bio (NUVB) United States $0.693B 0.00
HilleVax (HLVX) United States $0.686B 0.00
Mineralys Therapeutics (MLYS) United States $0.682B 0.00
EnGene Holdings (ENGN) United States $0.675B 0.00
Castle Biosciences (CSTL) United States $0.674B 0.00
Novavax (NVAX) United States $0.668B 0.00
CureVac (CVAC) Germany $0.659B 0.00
Pharming Group (PHAR) Netherlands $0.653B 0.00
Nurix Therapeutics (NRIX) United States $0.650B 0.00
Prime Medicine (PRME) United States $0.648B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.648B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Zymeworks (ZYME) United States $0.641B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.634B 0.00
Oric Pharmaceuticals (ORIC) United States $0.632B 0.00
Pharming Group (PHGUF) Netherlands $0.622B 0.00
Stoke Therapeutics (STOK) United States $0.619B 0.00
Olema Pharmaceuticals (OLMA) United States $0.610B 0.00
GH Research (GHRS) Ireland $0.608B 0.00
Cabaletta Bio (CABA) United States $0.602B 0.00
Kyverna Therapeutics (KYTX) United States $0.602B 0.00
IGM Biosciences (IGMS) United States $0.590B 0.00
Absci (ABSI) United States $0.589B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.583B 0.00
ArriVent BioPharma (AVBP) United States $0.577B 0.00
Aerovate Therapeutics (AVTE) United States $0.575B 0.00
Applied Therapeutics (APLT) United States $0.548B 0.00
Northwest Biotherapeutics (NWBO) United States $0.544B 0.00
Celcuity (CELC) United States $0.543B 0.00
Humacyte (HUMA) United States $0.541B 0.00
Astria Therapeutics (ATXS) United States $0.537B 0.00
Avid Bioservices (CDMO) United States $0.535B 0.00
Shattuck Labs (STTK) United States $0.532B 0.00
Arbutus Biopharma (ABUS) United States $0.528B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Oculis Holding AG (OCS) Switzerland $0.515B 0.00
Allogene Therapeutics (ALLO) United States $0.514B 0.00
Alector (ALEC) United States $0.513B 0.00
Travere Therapeutics (TVTX) United States $0.499B 0.00
Voyager Therapeutics (VYGR) United States $0.486B 2.89
Fulcrum Therapeutics (FULC) United States $0.482B 0.00
Fate Therapeutics (FATE) United States $0.480B 0.00
Third Harmonic Bio (THRD) United States $0.479B 0.00
Adaptive Biotechnologies (ADPT) United States $0.475B 0.00
Adlai Nortye (ANL) Cayman Islands $0.470B 0.00
Editas Medicine (EDIT) United States $0.465B 0.00
C4 Therapeutics (CCCC) United States $0.462B 0.00
Entrada Therapeutics (TRDA) United States $0.455B 0.00
PepGen (PEPG) United States $0.452B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.451B 0.00
ITeos Therapeutics (ITOS) United States $0.446B 0.00
Biomea Fusion (BMEA) United States $0.441B 0.00
Annexon (ANNX) United States $0.438B 0.00
ACELYRIN, INC (SLRN) United States $0.432B 0.00
Replimune (REPL) United States $0.430B 0.00
Revance Therapeutics (RVNC) United States $0.427B 0.00
Mersana Therapeutics (MRSN) United States $0.425B 0.00
Neurogene (NGNE) United States $0.422B 0.00
TScan Therapeutics (TCRX) United States $0.422B 0.00
Ocugen (OCGN) United States $0.419B 0.00
Anika Therapeutics (ANIK) United States $0.413B 0.00
MaxCyte (MXCT) United States $0.409B 0.00
Amarin (AMRN) Ireland $0.402B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.387B 0.00
Alto Neuroscience (ANRO) United States $0.384B 0.00
Erasca (ERAS) United States $0.383B 0.00
Aura Biosciences (AURA) United States $0.381B 0.00
Rani Therapeutics Holdings (RANI) United States $0.379B 0.00
Solid Biosciences (SLDB) United States $0.379B 0.00
Terns Pharmaceuticals (TERN) United States $0.374B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.369B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.365B 0.00
Precigen (PGEN) United States $0.358B 0.00
Tenaya Therapeutics (TNYA) United States $0.356B 0.00
Nautilus Biotechnology (NAUT) United States $0.353B 0.00
Nkarta (NKTX) United States $0.351B 0.00
Caribou Biosciences (CRBU) United States $0.346B 0.00
Jasper Therapeutics (JSPR) United States $0.338B 0.00
Atea Pharmaceuticals (AVIR) United States $0.337B 0.00
Ventyx Biosciences (VTYX) United States $0.332B 0.00
Kamada (KMDA) Israel $0.328B 24.83
MeiraGTx Holdings (MGTX) United States $0.326B 0.00
Urogen Pharma (URGN) United States $0.325B 0.00
CorMedix Inc (CRMD) United States $0.323B 0.00
Anavex Life Sciences (AVXL) United States $0.315B 0.00
Inozyme Pharma (INZY) United States $0.302B 0.00
Verastem (VSTM) United States $0.300B 0.00
CytomX Therapeutics (CTMX) United States $0.298B 0.00
XOMA (XOMA) United States $0.291B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.290B 0.00
Rapt Therapeutics (RAPT) United States $0.288B 0.00
ChromaDex (CDXC) United States $0.287B 0.00
XBiotech (XBIT) United States $0.286B 0.00
FibroBiologics (FBLG) United States $0.285B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.284B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.282B 96.80
Invivyd (IVVD) United States $0.281B 0.00
Inovio Pharmaceuticals (INO) United States $0.278B 0.00
Poseida Therapeutics (PSTX) United States $0.274B 0.00
Contineum Therapeutics (CTNM) United States $0.271B 0.00
Prima BioMed (IMMP) Australia $0.264B 0.00
Agenus (AGEN) United States $0.263B 0.00
Werewolf Therapeutics (HOWL) United States $0.260B 0.00
Candel Therapeutics (CADL) United States $0.260B 0.00
2seventy Bio (TSVT) United States $0.254B 0.00
Coherus BioSciences (CHRS) United States $0.252B 0.00
Codexis (CDXS) United States $0.251B 0.00
Sutro Biopharma (STRO) United States $0.243B 0.00
AC Immune (ACIU) Switzerland $0.237B 0.00
23andMe Holding (ME) United States $0.235B 0.00
Compass Therapeutics (CMPX) United States $0.234B 0.00
UniQure (QURE) Netherlands $0.226B 0.00
G1 Therapeutics (GTHX) United States $0.223B 0.00
Puma Biotechnology (PBYI) United States $0.223B 14.00
Adverum Biotechnologies (ADVM) United States $0.221B 0.00
Boundless Bio (BOLD) $0.218B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.218B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.214B 0.00
Ovid Therapeutics (OVID) United States $0.214B 0.00
Renovaro (RENB) United States $0.213B 0.00
Emergent Biosolutions (EBS) United States $0.209B 0.00
Trevi Therapeutics (TRVI) United States $0.207B 0.00
Kodiak Sciences (KOD) United States $0.207B 0.00
Design Therapeutics (DSGN) United States $0.206B 0.00
Elevation Oncology (ELEV) United States $0.204B 0.00
INmune Bio (INMB) United States $0.204B 0.00
Akoya Biosciences (AKYA) United States $0.203B 0.00
Zura Bio (ZURA) United States $0.202B 0.00
Lifecore Biomedical (LFCR) United States $0.202B 0.00
X4 Pharmaceuticals (XFOR) United States $0.202B 0.00
Innate Pharma S.A (IPHA) France $0.201B 0.00
Opthea (OPT) Australia $0.201B 0.00
Alimera Sciences (ALIM) United States $0.196B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.188B 0.00
Compugen (CGEN) Israel $0.186B 0.00
Cellectis S.A (CLLS) France $0.186B 0.00
Inventiva S.A (IVA) France $0.180B 0.00
Seres Therapeutics (MCRB) United States $0.180B 0.00
Greenwich LifeSciences (GLSI) United States $0.179B 0.00
Gossamer Bio (GOSS) United States $0.177B 0.00
GENFIT S.A (GNFT) France $0.176B 0.00
ScPharmaceuticals (SCPH) United States $0.171B 0.00
Adocia (ADOCY) France $0.169B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.164B 0.00
Skye Bioscience (SKYE) United States $0.160B 0.00
Cardiff Oncology (CRDF) United States $0.155B 0.00
BioAtla (BCAB) United States $0.152B 0.00
CervoMed (CRVO) United States $0.150B 0.00
Seer (SEER) United States $0.145B 0.00
I-Mab (IMAB) China $0.145B 0.00
Repare Therapeutics (RPTX) Canada $0.144B 0.00
Scilex Holding (SCLX) United States $0.144B 0.00
BioStem Technologies (BSEM) $0.139B 0.00
Nuvectis Pharma (NVCT) United States $0.139B 0.00
Adicet Bio (ACET) United States $0.139B 0.00
Cartesian Therapeutics (RNAC) United States $0.138B 0.00
PDS Biotechnology (PDSB) United States $0.137B 0.00
Sagimet Biosciences (SGMT) United States $0.137B 0.00
Syros Pharmaceuticals (SYRS) United States $0.136B 0.00
DiaMedica Therapeutics (DMAC) United States $0.133B 0.00
Molecular Partners AG (MOLN) Switzerland $0.131B 0.00
Rezolute (RZLT) United States $0.131B 0.00
Abeona Therapeutics (ABEO) United States $0.131B 0.00
DBV Technologies S.A (DBVT) France $0.129B 0.00
Omega Therapeutics (OMGA) United States $0.126B 0.00
VistaGen Therapeutics (VTGN) United States $0.125B 0.00
Coya Therapeutics (COYA) United States $0.122B 0.00
Immunic (IMUX) United States $0.121B 0.00
Vor Biopharma (VOR) $0.119B 0.00
ATyr Pharma (LIFE) United States $0.115B 0.00
TELA Bio (TELA) United States $0.113B 0.00
Oncobiologics (OTLK) United States $0.111B 0.00
Bluebird Bio (BLUE) United States $0.109B 0.00
Sangamo Therapeutics (SGMO) United States $0.109B 0.00
Vigil Neuroscience (VIGL) United States $0.109B 0.00
Allakos (ALLK) United States $0.104B 0.00
Genelux (GNLX) United States $0.103B 0.00
Gritstone Bio (GRTS) United States $0.103B 0.00
Adagene (ADAG) China $0.102B 0.00
Cue Biopharma (CUE) United States $0.101B 0.00
BioHarvest Sciences (CNVCF) Canada $0.099B 0.00
IO Biotech (IOBT) Denmark $0.098B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.096B 0.00
Eton Pharmaceuticals (ETON) United States $0.096B 0.00
Clearside Biomedical (CLSD) United States $0.096B 0.00
Curis (CRIS) United States $0.095B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.094B 0.00
BioXcel Therapeutics (BTAI) United States $0.093B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.092B 0.00
Elicio Therapeutics (ELTX) United States $0.092B 0.00
Spero Therapeutics (SPRO) United States $0.089B 3.32
Oncolytics Biotech (ONCY) Canada $0.089B 0.00
BeyondSpring (BYSI) United States $0.089B 0.00
HOOKIPA Pharma (HOOK) United States $0.087B 0.00
Passage Bio (PASG) United States $0.087B 0.00
Connect Biopharma Holdings (CNTB) United States $0.087B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.086B 0.00
Q32 Bio (QTTB) United States $0.084B 0.00
Affimed (AFMD) Germany $0.084B 0.00
Leap Therapeutics (LPTX) United States $0.082B 0.00
Alpha Teknova (TKNO) United States $0.081B 0.00
Cognition Therapeutics (CGTX) United States $0.080B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.078B 0.00
AN2 Therapeutics (ANTX) United States $0.077B 0.00
InflaRx (IFRX) Germany $0.076B 0.00
Atara Biotherapeutics (ATRA) United States $0.076B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.076B 0.00
Athira Pharma (ATHA) United States $0.076B 0.00
Instil Bio (TIL) United States $0.075B 0.00
Galena Biopharma (SLS) United States $0.075B 0.00
VTv Therapeutics (VTVT) United States $0.074B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.074B 0.00
Precision BioSciences (DTIL) United States $0.074B 0.00
Lantern Pharma (LTRN) United States $0.074B 0.00
YS Biopharma (YS) China $0.072B 0.00
Rallybio (RLYB) United States $0.071B 0.00
Turnstone Biologics (TSBX) United States $0.070B 0.00
Elutia (ELUT) United States $0.070B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.069B 0.00
Landos Biopharma (LABP) United States $0.069B 0.00
Entera Bio (ENTX) Israel $0.069B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.067B 0.00
Aileron Therapeutics (ALRN) United States $0.067B 0.00
Bionano Genomics (BNGO) United States $0.067B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Genenta Science S.p.A (GNTA) Italy $0.064B 0.00
Ikena Oncology (IKNA) United States $0.063B 0.00
Cidara Therapeutics (CDTX) United States $0.062B 0.00
Kronos Bio (KRON) United States $0.062B 0.00
Immix Biopharma (IMMX) United States $0.062B 0.00
Aligos Therapeutics (ALGS) United States $0.061B 0.00
Equillium (EQ) United States $0.061B 0.00
CalciMedica (CALC) United States $0.061B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.061B 0.00
Celularity (CELU) United States $0.060B 0.00
Annovis Bio (ANVS) United States $0.059B 0.00
Kezar Life Sciences (KZR) United States $0.059B 0.00
LENZ Therapeutics (LENZ) United States $0.059B 0.00
Checkpoint Therapeutics (CKPT) United States $0.058B 0.00
AVROBIO (AVRO) United States $0.056B 0.00
Enzo Biochem (ENZ) United States $0.055B 0.00
Clene (CLNN) United States $0.054B 0.00
Prenetics Global (PRE) Cayman Islands $0.053B 0.00
Ocuphire Pharma (OCUP) United States $0.051B 0.00
Intensity Therapeutics (INTS) United States $0.051B 0.00
Aadi Bioscience (AADI) United States $0.049B 0.00
Immuneering (IMRX) United States $0.049B 0.00
HCW Biologics (HCWB) United States $0.048B 0.00
Ocean Biomedical (OCEA) United States $0.048B 0.00
ARCA Biopharma (ABIO) United States $0.047B 0.00
NextCure (NXTC) United States $0.046B 0.00
Sensei Biotherapeutics (SNSE) United States $0.046B 0.00
Xilio Therapeutics (XLO) United States $0.046B 0.00
Beyond Air (XAIR) United States $0.045B 0.00
Eyenovia (EYEN) United States $0.045B 0.00
Cyclo Therapeutics (CYTH) United States $0.044B 0.00
Lexaria Bioscience (LEXX) Canada $0.044B 0.00
IN8bio (INAB) United States $0.043B 0.00
Cara Therapeutics (CARA) United States $0.043B 0.00
OKYO Pharma (OKYO) $0.043B 0.00
Dyadic (DYAI) United States $0.043B 0.00
Bolt Biotherapeutics (BOLT) United States $0.042B 0.00
Quince Therapeutics (QNCX) United States $0.041B 0.00
Carmell (CTCX) United States $0.039B 0.00
Promis Neurosciences (PMN) Canada $0.039B 0.00
Apollomics (APLM) United States $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.037B 0.00
SAB Biotherapeutics (SABS) United States $0.036B 0.00
BRIACELL THERAP (BCTX) Canada $0.036B 0.00
Fortress Biotech (FBIO) United States $0.034B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.033B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.033B 0.00
MiNK Therapeutics (INKT) United States $0.033B 0.00
Spruce Biosciences (SPRB) United States $0.031B 0.00
Dare Bioscience (DARE) United States $0.031B 0.00
NKGen Biotech (NKGN) United States $0.030B 0.00
Theratechnologies (THTX) Canada $0.030B 0.00
Femasys (FEMY) United States $0.030B 0.00
Evogene (EVGN) Israel $0.029B 0.00
Pluri (PLUR) Israel $0.029B 0.00
Aprea Therapeutics (APRE) United States $0.029B 0.00
Biora Therapeutics (BIOR) United States $0.027B 0.00
UNITY Biotechnology (UBX) United States $0.027B 0.00
Forte Biosciences (FBRX) United States $0.026B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.026B 0.00
Lumos Pharma (LUMO) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
BioAffinity Technologies (BIAF) United States $0.023B 0.00
Benitec Biopharma (BNTC) United States $0.022B 0.00
Synlogic (SYBX) United States $0.021B 0.00
RenovoRx (RNXT) United States $0.021B 0.00
Evaxion Biotech (EVAX) Denmark $0.020B 0.00
KALA BIO (KALA) United States $0.020B 0.00
Galecto (GLTO) Denmark $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.019B 0.00
Vincerx Pharma (VINC) United States $0.018B 0.00
Orgenesis (ORGS) United States $0.018B 0.00
Senti Biosciences (SNTI) United States $0.018B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.017B 0.00
Vaxxinity (VAXX) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.016B 0.00
Semper Paratus Acquisition (TVGN) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Monopar Therapeutics (MNPR) United States $0.014B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
Purple Biotech (PPBT) Israel $0.013B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
Elevai Labs (ELAB) United States $0.011B 0.00
ABVC BioPharma (ABVC) United States $0.011B 0.00
Moleculin Biotech (MBRX) United States $0.011B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.011B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.011B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Telesis Bio (TBIO) United States $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Eterna Therapeutics (ERNA) United States $0.010B 0.00
Psyence Biomedical (PBM) United States $0.009B 0.00
Chemomab Therapeutics (CMMB) Israel $0.009B 0.00
Galera Therapeutics (GRTX) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Cadrenal Therapeutics (CVKD) United States $0.008B 0.00
Virios Therapeutics (VIRI) United States $0.008B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Trevena (TRVN) United States $0.008B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Palisade Bio (PALI) United States $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
Kineta (KA) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Kintara Therapeutics (KTRA) United States $0.006B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
TFF Pharmaceuticals (TFFP) United States $0.005B 0.00
ThermoGenesis Holdings (THMO) United States $0.005B 0.00
First Wave BioPharma (FWBI) United States $0.005B 0.00
Cingulate (CING) United States $0.005B 0.00
Seelos Therapeutics (SEEL) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Novogen (KZIA) Australia $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.30
Soligenix (SNGX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Longeveron (LGVN) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Invo BioScience (INVO) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00